A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab

Clinical Kidney Journal · Published 2026-06-10 · DOI 10.1093/ckj/sfag198

Free full text

Authors (5)

Naga Sumanth Reddy Gopireddy, Abhishek Kumar, Richard J H Smith, Carla M Nester, Christie P Thomas

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gopireddy, N., Kumar, A., Smith, R., et al. (2026). A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab. Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfag198

Related articles

• Patient’s view on: decreasing cardiovascular events after kidney transplantation: a Finnish analysis covering 1990 to 2019 · Clinical Kidney Journal · 2026 · Same journal
• Vitamin K and vascular calcification: from biological plausibility to clinical realism · Clinical Kidney Journal · 2026 · Same journal
• Trends in the management and coding of chronic kidney disease in Spain: cross-sectional analyses of real-life data with a 5-year interval · Clinical Kidney Journal · 2026 · Same journal
• Similar predictive performance and clinical utility of the Kidney Failure Risk Equation using EKFC or CKD-EPI estimated glomerular filtration rate · Clinical Kidney Journal · 2026 · Same journal
• Higher cardiovascular risk observed with beta-blockers in CKD patients without prior cardiovascular disease · Clinical Kidney Journal · 2026 · Same journal
• Changing prognostic significance of peritoneal transport status in contemporary incident peritoneal dialysis patients · Clinical Kidney Journal · 2026 · Same journal
• Association between long-term exposure to particulate matter 2.5 and the risk of rapid renal function decline: a prospective study from CHARLS · Clinical Kidney Journal · 2026 · Same journal
• Drowning the kidneys: from fluid overload to physiology-guided fluid management in onco-hematology · Clinical Kidney Journal · 2026 · Same journal
• Improving quality of life in older dialysis patients: the case for broader functional assessment · Clinical Kidney Journal · 2026 · Same journal
• Treatment response to daratumumab in antibody-mediated kidney allograft rejection: evidence from serial protocol biopsies · Clinical Kidney Journal · 2026 · Same journal